Sentence examples for probability of assay from inspiring English sources

The unique platform significantly reduced the probability of assay failure (under 1%), which is of critical importance in practical use when dealing with clinically rare samples.

The call with maximum posterior probability is assigned and then the maximum likelihood estimates of the model parameters, assuming these genotype calls, are computed, including the A allele frequency p j and probability of assay failure z j.

The mispriming probabilities of Assay 2 and the results presented in Additional file 1 illustrated that PCR conditions can be modulated to minimize the influence of SNPs, thereby reducing the large number of aberrant measurements of gene expression that could be expected due to SNPs present in primer binding sites.

The CV of the assay was assumed to be 3%; the penetrance values are proportional to the probability of an assay value of 0.675 given the genotype As the stud Merino sheep industry is likely to use a test for the genotype at the Agouti locus, small, highly selected and relatively closed flocks were simulated.

We propose a random walk process for the Ag-carrying bead over the magnetic landscape of small beads and this model description explains the enhanced overall capture probability of this assay and its particular non-linear dose response curves.

As more cases not "formally" suffering from IFD are included as diseased, there is a decrease in the pre-test-probability, thus further reducing the sensitivity of the test from 36%to26%6%, as depicted in Table 2. Secondly, previous studies selected patients by definite radiographic findings or pneumonia, thus improving the pre-test probability of the assay [ 18, 29].

Similarly, the nuisance parameter z j (probability of an assay failing for a individual at SNP j) is also estimated via EM in tandem with the model parameters and A allele frequency, with initial values being proposed from the Beta(1,20) distribution.

These results suggest that the number of genome-specific SNP s) in the assay primers is positively correlated with the probability of a SNP assay performing as a codominant assay, and that a genome-specific SNP closer to the 3′ end of the assay primers is more useful for ensuring this behavior, but are not always effective.

Crude estimates of the probability of a positive assay ('positivity') for different subgroups were obtained by simple ratios.

The discriminatory power for the combined set of VNTR markers was 83.3%, indicating the high probability of the MLVA assay separating two isolates from different diagnostic cases.

Note that in the absence of a threshold the model reduces to a constant probability of infection independent of assay value.